Forrest Hu | General Manager of International Business
3SBio Inc

Forrest Hu, General Manager of International Business, 3SBio Inc

Mr HU is working for 3S Pharmaceutical Group, which includes the main subsidiaries such as Shanghai CP Guojian, Shengyan SunShine, Zhejiang Wangshen, Shenzheng Sciprogen and Italy Sirton. Mr HU is the General Manager of International Business Unit of the Group. Mr HU is in charge of the International Sales, Business Development, Global Strategic Cooperation, as well as Regulatory Affairs, etc. MR HU has many years' experience in fields of like quality, production, R&D, international business, as well as BD affairs (license in & out). 3S Pharma is one of the largest listed pharmaceutical companies in Hong Kong stock market(01530.HK), with the main marketing products like: Etanercept(launched in 10 countries), Daclizumab, EPO(launched in 22 countries), TPO(launched in 5 countries), Interferon-Alpha, etc.


Biosimilars Day 1 - Tuesday 31st October 2017 @ 16:50

Challenges & strategies to develop emerging markets for biosimilars

  • Main challenges in emerging market
  • Suitable and feasible strategies in different territories
  • New Regulations & Opportunities for biosimilar business in China

back to speakers